Our History
Our milestones are an indication of our unwavering determination to move forward into the future.
1998
established
ROXALL Medizin was founded in Hamburg, Germany, with extensive expertise in immunotherapy.
2008
ROXALL Türkiye
established
ROXALL Medizin expanded its presence by opening its first branch in Türkiye.
2010
ROXALL Austria
established
ROXALL Medizin continued to grow by opening a branch in Austria. With this step, it became the ROXALL Group.
2011
ROXALL Italy
established
Italy has become part of the ROXALL Group's headquarters locations.
2017
ROXALL Spain
established
The acquisition of the allergy line in Bilbao, Spain (BIAL Aristegui) has laid a solid foundation for current operations and future growth.
Immunotherapy research has been the primary focus of this facility for over 70 years.
2021
Expansion beyond Europe.
Key markets: Eurasia and Latin America.
2026
We strengthen each of our locations and continue to grow with each of our branches.
Our goal is to continue our innovative R&D activities on this path to the future and to maintain our highly tareted immunotherapies.
